Introduction Psoriasis is a common, chronic immune-mediated skin disease frequently
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …

Psoriasis is a T cell-mediated inflammatory disease associated with comorbidities impacting
the overall health and quality of life of those affected. This article offers a brief overview of …

Introduction Psoriasis is currently regarded an immune-mediated inflammatory disease. The
central pathogenic axis comprises interleukin-23, TH17-lymphocytes differentiating under its …

Introduction Psoriasis is a chronic inflammatory skin disease often associated with several
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …

Biological therapies in moderate and severe psoriasis: perspectives and certainties - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Biological therapy has revolutionized moderate to severe psoriasis treatment. However,
despite being more effective than conventional systemic treatments, some patients do not …

What is known and objective To assess the equivalent efficacy of two or more treatments,
clinical relevance must be adequately established, but there appears to be some confusion …

Personalized medicine is the new frontier in psoriasis as it may allow a patient-tailored
management with treatment optimization and reduction of side effects as well as health costs …

Psoriasis is a common, chronic, inflammatory disease affecting millions of people around the
world. Presented in the first 5 parts of the American Academy of Dermatology Psoriasis …

In biological therapy, dose modification in carefully selected patients when psoriasis is in
remission can reduce both treatment costs and the risks associated with drug exposure, a …